T cell receptor mimic antibodies for cancer therapy Journal Article
| Authors: | Dubrovsky, L.; Dao, T.; Gejman, R. S.; Brea, E. J.; Chang, A. Y.; Oh, C. Y.; Casey, E.; Pankov, D.; Scheinberg, D. A. |
| Article Title: | T cell receptor mimic antibodies for cancer therapy |
| Abstract: | The major hurdle to the creation of cancer-specific monoclonal antibodies (mAb) exhibiting limited cross-reactivity with healthy human cells is the paucity of known tumor-specific or mutated protein epitopes expressed on the cancer cell surface. Mutated and overexpressed oncoproteins are typically cytoplasmic or nuclear. Cells can present peptides from these distinguishing proteins on their cell surface in the context of human leukocyte antigen (HLA). T cell receptor mimic (TCRm) mAb can be discovered that react specifically to these complexes, allowing for selective targeting of cancer cells. The state-of-the-art for TCRm and the challenges and opportunities are discussed. Several such TCRm are moving toward clinical trials now. © 2016 Taylor & Francis Group, LLC. |
| Keywords: | monoclonal antibody; immunotherapy; t cell receptor (tcr); tcr like antibody; tcr mimic antibody |
| Journal Title: | OncoImmunology |
| Volume: | 5 |
| Issue: | 1 |
| ISSN: | 2162-4011 |
| Publisher: | Landes Bioscience |
| Date Published: | 2016-01-01 |
| Start Page: | e1049803 |
| Language: | English |
| DOI: | 10.1080/2162402x.2015.1049803 |
| PROVIDER: | scopus |
| PMCID: | PMC4760335 |
| PUBMED: | 26942058 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 3 February 2016 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work